1. Home
  2. LEA vs HALO Comparison

LEA vs HALO Comparison

Compare LEA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lear Corporation

LEA

Lear Corporation

HOLD

Current Price

$135.66

Market Cap

7.2B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$74.99

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEA
HALO
Founded
1917
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.1B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
LEA
HALO
Price
$135.66
$74.99
Analyst Decision
Buy
Buy
Analyst Count
14
11
Target Price
$132.21
$78.64
AVG Volume (30 Days)
677.0K
1.6M
Earning Date
05-01-2026
05-05-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
N/A
EPS
3.34
1.22
Revenue
$23,259,100,000.00
$151,862,000.00
Revenue This Year
$2.50
$28.24
Revenue Next Year
$3.12
$12.56
P/E Ratio
$41.38
$59.53
Revenue Growth
N/A
N/A
52 Week Low
$91.67
$51.06
52 Week High
$150.33
$82.22

Technical Indicators

Market Signals
Indicator
LEA
HALO
Relative Strength Index (RSI) 44.11 66.87
Support Level $115.63 $62.53
Resistance Level $141.92 $79.50
Average True Range (ATR) 4.06 2.20
MACD -1.29 0.30
Stochastic Oscillator 9.91 84.09

Price Performance

Historical Comparison
LEA
HALO

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: